1-15 of 135
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
Diabetes DiscourseAddressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Diabetes DiscourseEnhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Laura Chiavaroli, PhD
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
Diabetes DiscourseInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
Edward Phelps, PhD
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Diabetes DiscourseInvestigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Vira Kravets, PhD
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Diabetes DiscourseUnanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Edward Phelps, PhD
Assessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
On the Frontlines of PsoriasisAssessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
Mary Leuchars, MD
Jeffrey Cohen, MD, MPH
- advertisement
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
The Long Road to an FCS Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeThe Long Road to an FCS Diagnosis
Charles Turck, PharmD, BCPS, BCCCP
Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FCCP, FACC
Could It Be FCS? Recognizing the Diagnostic Clues
On the Frontlines of Familial Chylomicronemia SyndromeCould It Be FCS? Recognizing the Diagnostic Clues
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Zahid Ahmad, MD, FNLA
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Living RheumHow Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeFamilial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD
Nivedita Patni, MD
- advertisement
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart MattersHypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD
Payal Kohli, MD, FACC
Understanding the Biology and Burden of Postpartum Depression
Advances in Women's HealthUnderstanding the Biology and Burden of Postpartum Depression
Jennifer L. Payne, MD
Conference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
EndocrinologyConference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
Ravi Savarirayan, MBBS, MD